THE DEVELOPMENT OF METHOD FOR ACTIVATING PHARMACEUTICAL SUBSTANCES WITH SUBSEQUENT IN SITU STUDY OF MODIFIED POWDER PROPERTIES

ELENA USPENSKAYA; EKATERINA S. KUZMINA; HOANG T. N. QUYNH; ALEKSEY A. TIMOFEEV; TATIANA V. MAXIMOVA

doi:10.22159/ijap.2024v16i5.51481

Authors

ELENA USPENSKAYA Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, RUDN University, Miklukho-Maklaya 8, Moscow-117198, Russia https://orcid.org/0000-0003-2147-8348
EKATERINA S. KUZMINA Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, Peoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), Russia
HOANG T. N. QUYNH Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, Peoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), Russia https://orcid.org/0009-0000-9154-5695
ALEKSEY A. TIMOFEEV Institute of Biochemical Technology and Nanotechnology, Peoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), Russia
TATIANA V. MAXIMOVA Department of Pharmaceutical and Toxicological Chemistry, Medical Institute, Peoples' Friendship University of Russia Named After Patrice Lumumba (RUDN University), Russia https://orcid.org/0000-0002-0464-7798

DOI:

https://doi.org/10.22159/ijap.2024v16i5.51481

Keywords:

Mechanical activation, Antiepileptic drug, Surface defects, Knife mill, In situ study, Amorphization, Spirotox biotesting

Abstract

Objective: The aim of this work is to develop a method of activation of pharmaceutical substances by means of a mechanical load on the powder of the substance with the subsequent evaluation on site of the modified preparation. A complex of analytical methods and biotesting were used to characterize the solid-state phase transformation product.

Methods: The object of study was powder of the antiepileptic substance Lacosamide (Lcs); Mechanical Activation (MA) of Active Pharmaceutical Ingredient (API) was carried out using the Stegler LM-250 rotary knife mill; Fourier-Transform Infra-Red (FT-IR) spectroscopy in the range of 4000-400 cm^-1 was used to analyses the band shift in the spectrum; Dynamic Laser Scattering (DLS) has been used to detect groups of particles ranging in size from 0 to 1000 nm; an innovative method of Two-Dimensional Diffuse Light Scattering (2D-DLS) was used to detect differences in the speckle structure of powder samples before and after modification; Scanning Electron Microscopy (SEM) was used to evaluate particle morphology; X-Ray Fluorescence analysis (XRF) was used to determine the elemental composition of the samples; polarimetry was used to determine the optical activity and Spirotox biotesting has been used to evaluate the biological activity.

Results: SEM images of the sample after activation represent a glassy, structurally amorphous state in contrast to the native state. Chemometric processing of FT-IR spectra allowed us to identify the regions of the samples at different activation times on the 2D-diagram of Principal Components Analysis (PCA). According to the XRF data, the elements Fe, Cu, and Zn are predominant in the Lcs-activated sample. The 2D-DLS method revealed differences in speckle structure between samples before and after mechanical activation. The same optical activity of the solutions of the studied samples with preservation of the chiral center was revealed. The Spirotox method showed a 1.6-fold (P≤0.05) increase in biological activity of the activated Lcs sample based on the calculated values of activation energy (^bsE_a) of the process of cellular transitions to the immobilized state.

Conclusion: The developed method of activation of pharmaceutical substances includes a full cycle of 90 min mechanical load chemistry duration with the description of technical equipment and conditions. The results of this study can be used in the pharmaceutical industry to produce preparations with improved physical-chemical and biopharmaceutical properties.

Downloads

Download data is not yet available.

References

Boyd BJ, Bergstrom CA, Vinarov Z, Kuentz M, Brouwers J, Augustijns P. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur J Pharm Sci. 2019;137(1):104967. doi: 10.1016/j.ejps.2019.104967, PMID 31252052.

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1-3):3-26. doi: 10.1016/s0169-409x(00)00129-0, PMID 11259830.

Benet LZ, Hosey CM, Ursu O, Oprea TI. BDDCS, the rule of 5 and drugability. Adv Drug Deliv Rev. 2016;1(101):89-98. doi: 10.1016/j.addr.2016.05.007, PMID 27182629.

Lipinski CA. Lead and drug-like compounds: the rule of five revolution. Drug Discov Today Technol. 2004;1(4):337-41. doi: 10.1016/j.ddtec.2004.11.007, PMID 24981612.

Jays J, Saravanan JA. Molecular modelling approach for structure-based virtual screening and identification of novel isoxazoles as potential antimicrobial agents against S. aureus. Int J Pharm Pharm Sci. 2024;16(4):36-41. doi: 10.22159/ijpps.2024v16i4.49731.

Shaikh SC, Saboo SG, Tandale PS, Memon FS, Tayade SD, Haque MA. Pharmaceutical and biomedical applications of quantum dots an overview. Int J App Pharm. 2021;13(5):44-53. doi: 10.22159/ijap.2021v13i5.41623.

Grejtak T, Lacey JA, Kuns MW, Hartley DS, Thompson DN, Fenske G. Improving knife milling performance for biomass preprocessing by using advanced blade materials. Wear. 2023;522(1):204714. doi: 10.1016/j.wear.2023.204714.

Syroeshkin AV, Uspenskaya EV, Pleteneva TV, Morozova MA, Maksimova TV, Koldina AM. Mechanochemical activation of pharmaceutical substances as a factor for modification of their physical chemical and biological properties. Int J App Pharm. 2019;11(3):118-23. doi: 10.22159/ijap.2019v11i3.32413.

Solares Briones M, Coyote Dotor G, Paez Franco JC, Zermeno Ortega, Dela MR. Mechanochemistry: a green approach in the preparation of pharmaceutical cocrystals. Pharmaceutics. 2021;13(6):790. doi: 10.3390/pharmaceutics13060790, PMID 34070646.

Warner JC, Cannon AS, Dye KM. Green chemistry. Environ Impact Assess Rev. 2004;24(7-8):775-9. doi: 10.1016/j.eiar.2004.06.006.

Jug M, Mura PA. Grinding as solvent free green chemistry approach for cyclodextrin inclusion complex preparation in the solid state. Pharmaceutics. 2018;10(4):189. doi: 10.3390/pharmaceutics10040189, PMID 30332804.

Boldyrev VV. Mechanochemistry and mechanical activation of solids. Russ Chem Rev. 2006;75(3):177-89. doi: 10.1070/RC2006v075n03ABEH001205.

Sovic I, Lukin S, Mestrovic E, Halasz I, Porcheddu A, Delogu F. Mechanochemical preparation of active pharmaceutical ingredients monitored by in situ raman spectroscopy. ACS Omega. 2020;5(44):28663-72. doi: 10.1021/acsomega.0c03756, PMID 33195919.

PubChem. PubChem Compound Summary for CID 219078, Lacosamide. Bethesda: National Library of Medicine (US). National Center for Biotechnology Information; 2004. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/lacosamide. [Last accessed on 15 May 2024]

Munir MA, Inayatullah A, Ibrahim S, Rimba Putri IR, Emelda E, Fatmawati A. A modest uv spectrophotometric assisted by chemometric approach for verification of acetaminophen level in various manufactured tablets and syrups in Indonesian pharmacies. Int J App Pharm. 2023;15(1):195-205. doi: 10.22159/ijap.2023v15i1.46290.

Li Q, Wu Z, Lin L, Zeng J, Zhang J, Yan H. High-level fusion coupled with mahalanobis distance weighted (MDW) method for multivariate calibration. Sci Rep. 2020;10(1):5478. doi: 10.1038/s41598-020-62396-y, PMID 32214179.

Makarova MP, Syroeshkin AV, Maksimova TV, Matveeva IS, Pleteneva TV. Features of microelements express determination in medicinal and nonoficinal plants by x-ray-fluorescence analysis. Razrabotka i Registracia Lekarstvennyh Sredstv Regist 2019;8(2):93-7. doi: 10.33380/2305-2066-2019-8-2-93-97.

Butyagin PY. Structural disorder and mechanochemical reactions in solids. Russ Chem Rev. 1984;53(11):1025-38. doi: 10.1070/RC1984v053n11ABEH003138.

Auvray T, Friscic T. Shaking things from the ground-up: a systematic overview of the mechanochemistry of hard and high melting inorganic materials. Molecules. 2023;28(2):897. doi: 10.3390/molecules28020897, PMID 36677953.

Speight IR, Hanusa TP. Exploration of mechanochemical activation in solid-state fluoro-grignard reactions. Molecules. 2020;25(3):570. doi: 10.3390/molecules25030570, PMID 32012963.

Ma D, Hettiarachchi G, Nguyen D, Zhang B, Wittenberg JB, Zavalij PY. Acyclic cucurbit[n]uril molecular containers enhance the solubility and bioactivity of poorly soluble pharmaceuticals. Nat Chem. 2012;4(6):503-10. doi: 10.1038/nchem.1326, PMID 22614387.

Rietveld IB. Solid-solid phase transitions between crystalline polymorphs of organic materials. Curr Pharm Des. 2023;29(6):445-61. doi: 10.2174/1381612829666221221114459, PMID 36545715.

Iyer J, Brunsteiner M, Modhave D, Paudel A. Role of crystal disorder and mechanoactivation in solid state stability of pharmaceuticals. J Pharm Sci. 2023;112(6):1539-65. doi: 10.1016/j.xphs.2023.02.019, PMID 36842482.

Lu M, Fatah N, Khodakov AY. And high optimization of solvent-free mechanochemical synthesis of Co/Al2O3 catalysts using low and high-energy processes. J Mater Sci. 2017;52(20):12031-43. doi: 10.1007/s10853-017-1299-8.

Engblom J, Hyde ST. On the swelling of bicontinuous lyotropic mesophases. J Phys II France. 1995;5(1):171-90. doi: 10.1051/jp2:1995121.

Uspenskaya E, Simutina A, Kuzmina E, Sukhanova V, Garaev T, Pleteneva T. Exploring the effects of cramped impact type mechanical action on active pharmaceutical ingredient (levofloxacin) prospects for pharmaceutical applications. Powders. 2023;2(2):464-83. doi: 10.3390/powders2020028.

Stachurski ZH. On structure and properties of amorphous materials. Materials (Basel). 2011;4(9):1564-98. doi: 10.3390/ma4091564, PMID 28824158.

Khajapeer KV, Baskaran KPP R. GC MS and elemental analysis of Cinnamomumtamala. Int J Pharm Pharm Sci. 2015;8(8):398-402.

Gallington LC, Ghadar Y, Skinner LB, Weber JK, Ushakov SV, Navrotsky A. The structure of liquid and amorphous hafnia. Materials (Basel). 2017;10(11):1290. doi: 10.3390/ma10111290, PMID 29125579.

Wu G, Zheng X, Cui P, Jiang H, Wang X, Qu Y. A general synthesis approach for amorphous noble metal nanosheets. Nat Commun. 2019;10(1):4855. doi: 10.1038/s41467-019-12859-2, PMID 31649272.

Priemel PA, Grohganz H, Rades T. Unintended and in situ amorphisation of pharmaceuticals. Adv Drug Deliv Rev. 2016;100(1):126-32. doi: 10.1016/j.addr.2015.12.014, PMID 26724250.

Jud K, Kausch HH, Williams JG. Fracture mechanics studies of crack healing and welding of polymers. J Mater Sci. 1981;16(1):204-10. doi: 10.1007/BF00552073.

Mayerhofer TG, Popp J. Quantitative evaluation of infrared absorbance spectra lorentz profile versus lorentz oscillator. ChemPhysChem. 2019;20(1):31-6. doi: 10.1002/cphc.201800961, PMID 30480862.

Butyagin PY. Kinetics and nature of mechanochemical reactions. Russ Chem Rev. 1971;40(11):901-15. doi: 10.1070/RC1971v040n11ABEH001982.

Chang JH, Chou CH, Wu JC, Liao KM, Luo WJ, Hsu WL. LCRMP-1 is required for spermatogenesis and stabilises spermatid f-actin organization via the pi3k-akt pathway. Commun Biol. 2023;6(1):389. doi: 10.1038/s42003-023-04778-2, PMID 37037996.

Lees G, Stohr T, Errington AC. Stereoselective effects of the novel anticonvulsant lacosamide against 4-AP induced epileptiform activity in rat visual cortex in vitro. Neuropharmacology. 2006;50(1):98-110. doi: 10.1016/j.neuropharm.2005.08.016, PMID 16225894.